Rodrigo A Toledo1, Patricia L M Dahia. 1. aDivision of Hematology and Medical Oncology, Department of Medicine bCancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, Texas, USA.
Abstract
PURPOSE OF REVIEW: About 40% of the neuroendocrine tumors pheochromocytomas and paragangliomas (PPGLs) are caused by an inherited mutation. Diagnostic genetic screening is recommended for patients and their families. However, the number of susceptibility genes involved is high and continues to grow, making conventional sequencing costly and burdensome. Next-generation sequencing (NGS) enables accurate, thorough, and cost-effective identification of inherited mutations. Here we review recent successes, limitations, and the future of NGS for diagnosis of pheochromocytoma and paraganglioma syndromes. RECENT FINDINGS: NGS-based screen of genetic disorders in the clinical setting shows improved diagnostic rates over conventional tests. Both broad, whole-exome sequencing, and targeted NGS approaches have been tested for screening of PPGLs, with accurate mutation detection, higher speed, and reduced costs compared with current assays. Flexibility to expand the targeted gene set is immediate in whole-exome sequencing, and adjustable in targeted NGS, but both methods have limitations. SUMMARY: The high degree of genetic heterogeneity and heritability of PPGLs make NGS an ideal medium for their diagnostic screening. However, improved detection of large genomic defects and underrepresented gene areas are needed before NGS can fully realize its potential as the premier option for routine genetic testing of these syndromes.
PURPOSE OF REVIEW: About 40% of the neuroendocrine tumors pheochromocytomas and paragangliomas (PPGLs) are caused by an inherited mutation. Diagnostic genetic screening is recommended for patients and their families. However, the number of susceptibility genes involved is high and continues to grow, making conventional sequencing costly and burdensome. Next-generation sequencing (NGS) enables accurate, thorough, and cost-effective identification of inherited mutations. Here we review recent successes, limitations, and the future of NGS for diagnosis of pheochromocytoma and paraganglioma syndromes. RECENT FINDINGS: NGS-based screen of genetic disorders in the clinical setting shows improved diagnostic rates over conventional tests. Both broad, whole-exome sequencing, and targeted NGS approaches have been tested for screening of PPGLs, with accurate mutation detection, higher speed, and reduced costs compared with current assays. Flexibility to expand the targeted gene set is immediate in whole-exome sequencing, and adjustable in targeted NGS, but both methods have limitations. SUMMARY: The high degree of genetic heterogeneity and heritability of PPGLs make NGS an ideal medium for their diagnostic screening. However, improved detection of large genomic defects and underrepresented gene areas are needed before NGS can fully realize its potential as the premier option for routine genetic testing of these syndromes.
Authors: Michael J Bamshad; Sarah B Ng; Abigail W Bigham; Holly K Tabor; Mary J Emond; Deborah A Nickerson; Jay Shendure Journal: Nat Rev Genet Date: 2011-09-27 Impact factor: 53.242
Authors: J Keith Killian; Markku Miettinen; Robert L Walker; Yonghong Wang; Yuelin Jack Zhu; Joshua J Waterfall; Natalia Noyes; Parvathy Retnakumar; Zhiming Yang; William I Smith; M Scott Killian; C Christopher Lau; Marbin Pineda; Jennifer Walling; Holly Stevenson; Carly Smith; Zengfeng Wang; Jerzy Lasota; Su Young Kim; Sosipatros A Boikos; Lee J Helman; Paul S Meltzer Journal: Sci Transl Med Date: 2014-12-24 Impact factor: 17.956
Authors: Colin C Pritchard; Christina Smith; Stephen J Salipante; Ming K Lee; Anne M Thornton; Alex S Nord; Cassandra Gulden; Sonia S Kupfer; Elizabeth M Swisher; Robin L Bennett; Akiva P Novetsky; Gail P Jarvik; Olufunmilayo I Olopade; Paul J Goodfellow; Mary-Claire King; Jonathan F Tait; Tom Walsh Journal: J Mol Diagn Date: 2012-05-30 Impact factor: 5.568
Authors: Garrett M Frampton; Alex Fichtenholtz; Geoff A Otto; Kai Wang; Sean R Downing; Jie He; Michael Schnall-Levin; Jared White; Eric M Sanford; Peter An; James Sun; Frank Juhn; Kristina Brennan; Kiel Iwanik; Ashley Maillet; Jamie Buell; Emily White; Mandy Zhao; Sohail Balasubramanian; Selmira Terzic; Tina Richards; Vera Banning; Lazaro Garcia; Kristen Mahoney; Zac Zwirko; Amy Donahue; Himisha Beltran; Juan Miguel Mosquera; Mark A Rubin; Snjezana Dogan; Cyrus V Hedvat; Michael F Berger; Lajos Pusztai; Matthias Lechner; Chris Boshoff; Mirna Jarosz; Christine Vietz; Alex Parker; Vincent A Miller; Jeffrey S Ross; John Curran; Maureen T Cronin; Philip J Stephens; Doron Lipson; Roman Yelensky Journal: Nat Biotechnol Date: 2013-10-20 Impact factor: 54.908
Authors: Birgit Sikkema-Raddatz; Lennart F Johansson; Eddy N de Boer; Rowida Almomani; Ludolf G Boven; Maarten P van den Berg; Karin Y van Spaendonck-Zwarts; J Peter van Tintelen; Rolf H Sijmons; Jan D H Jongbloed; Richard J Sinke Journal: Hum Mutat Date: 2013-04-29 Impact factor: 4.878
Authors: Maria Currás-Freixes; Elena Piñeiro-Yañez; Cristina Montero-Conde; María Apellániz-Ruiz; Bruna Calsina; Veronika Mancikova; Laura Remacha; Susan Richter; Tonino Ercolino; Natalie Rogowski-Lehmann; Timo Deutschbein; María Calatayud; Sonsoles Guadalix; Cristina Álvarez-Escolá; Cristina Lamas; Javier Aller; Julia Sastre-Marcos; Conxi Lázaro; Juan C Galofré; Ana Patiño-García; Amparo Meoro-Avilés; Judith Balmaña-Gelpi; Paz De Miguel-Novoa; Milagros Balbín; Xavier Matías-Guiu; Rocío Letón; Lucía Inglada-Pérez; Rafael Torres-Pérez; Juan M Roldán-Romero; Cristina Rodríguez-Antona; Stephanie M J Fliedner; Giuseppe Opocher; Karel Pacak; Esther Korpershoek; Ronald R de Krijger; Laurent Vroonen; Massimo Mannelli; Martin Fassnacht; Felix Beuschlein; Graeme Eisenhofer; Alberto Cascón; Fátima Al-Shahrour; Mercedes Robledo Journal: J Mol Diagn Date: 2017-05-25 Impact factor: 5.568
Authors: Jin Wook Yi; Hye In Kang; Su-Jin Kim; Chan Yong Seong; Young Jun Chai; June Young Choi; Moon-Woo Seong; Kyu Eun Lee; Sung Sup Park Journal: Case Rep Endocrinol Date: 2018-04-15
Authors: Yuriy O Alekseyev; Roghayeh Fazeli; Shi Yang; Raveen Basran; Thomas Maher; Nancy S Miller; Daniel Remick Journal: Acad Pathol Date: 2018-05-06
Authors: Bernardo Dias Pereira; Tiago Nunes da Silva; Ana Teresa Bernardo; Rui César; Henrique Vara Luiz; Karel Pacak; Luísa Mota-Vieira Journal: Int J Endocrinol Date: 2018-03-20 Impact factor: 3.257
Authors: Diana E Benn; Ying Zhu; Katrina A Andrews; Mathilda Wilding; Emma L Duncan; Trisha Dwight; Richard W Tothill; John Burgess; Ashley Crook; Anthony J Gill; Rodney J Hicks; Edward Kim; Catherine Luxford; Helen Marfan; Anne Louise Richardson; Bruce Robinson; Arran Schlosberg; Rachel Susman; Lyndal Tacon; Alison Trainer; Katherine Tucker; Eamonn R Maher; Michael Field; Roderick J Clifton-Bligh Journal: J Med Genet Date: 2018-09-10 Impact factor: 6.318